Sponsors

Funding awarded to support an enzymatic process for DNA synthesis

Evonetix, the Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis, has been awarded substantial funding to support the development of a novel enzymatic approach to DNA synthesis. Innovate UK, the UK’s innovation agency, will co-fund the £1.3 million project, which will be undertaken in collaboration with Durham University.

Evonetix is revolutionising gene synthesis with the aim of producing DNA at scale to facilitate many

applications in the rapidly growing field of synthetic biology. Evonetix’s novel silicon array, combined with its unique synergistic thermal control chemistry and process of error detection throughout assembly, permits massive parallelism in de novo DNA synthesis, enabling high-throughput on-chip assembly of high-fidelity gene-length DNA at scale.

 

As part of the Innovate UK co-funded project, Evonetix will develop a novel enzymatic approach to gene synthesis and integrate it into its proprietary, thermally addressable silicon array. The research will be directed by Dr Raquel Sanches-Kuiper (Director of Biology, Evonetix [pictured]), whose group will develop engineered enzymes that are able to incorporate modified nucleotides efficiently. The group of Dr David Hodgson (Associate Professor of Chemistry, Durham University) will develop the modified nucleotides for enzymatic synthesis in Evonetix’s silicon array.

Latest Issues

DIA-MHRA Global Summit

Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026

UK NEQAS for Microbiology & Parasitology Annual Scientific Meeting 2026

The Royal National Hotel, 38 – 51 Bedford Way, London, WC1H 0DG
27 November, 2026

UK NEQAS webinar: Epigenetics

Online
1 December, 2026

Weqas Annual POCT Conference 2026

London, Venue - TBC
8-9 December, 2026

UK NEQAS webinar: Fresh Muscle Biopsies

Online
8 December, 2026